A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/16 (2006.01) A61K 31/192 (2006.01) A61K 31/196 (2006.01) A61K 31/343 (2006.01) A61K 31/395 (2006.01) A61K 31/40 (2006.01) A61K 31/403 (2006.01) A61K 31/427 (2006.01) A61K 31/454 (2006.01) A61K 31/496 (2006.01) A61K 31/4965 (2006.01) A61K 38/06 (2006.01) A61K 38/07 (2006.01) A61K 45/06 (2006.01) A61P 31/12 (2006.01)
Patent
CA 2647158
Disclosed are medicaments, pharmaceutical compositions, pharmaceutical kits, and methods based on combinations comprising, separately or together: (a) a CYP3A4 inhibitor; and (b) a HCV protease inhibitor; for concurrent or consecutive administration in treating a human subject infected with HCV.
La présente invention concerne des médicaments, des compositions pharmaceutiques, des kits pharmaceutiques et des méthodes reposant sur des combinaisons qui contiennent, séparément ou conjointement : (a) un inhibiteur de CYP3A4; et (b) un inhibiteur de la protéase du VHC. Lesdits médicaments, compositions pharmaceutiques et kits pharmaceutiques sont conçus pour une administration concurrente ou consécutive, aux fins de traitement d'un sujet humain atteint par le VHC.
Ghosal Anima
Gupta Samir K.
Mcleod James F.
O'mara Edward M.
Ralston Robert O. II
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Combinations of hcv protease inhibitor(s) and cyp3a4... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations of hcv protease inhibitor(s) and cyp3a4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of hcv protease inhibitor(s) and cyp3a4... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1603209